The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Barriers and facilitators to enrolling in a cancer clinical trial financial reimbursement program.
 
Vivian Nguyen
No Relationships to Disclose
 
Elizabeth Ramos
No Relationships to Disclose
 
Dana Dornsife
Stock and Other Ownership Interests - GenVivo
Research Funding - Amgen (Inst); Amgen (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Patents held in part by David Dornsife, husband, in GenVivo - an immunotherapy oncology company (I)
Other Relationship - GenVivo
 
Robert G. Johnson
Employment - GenVivo; Ipsen (I)
Leadership - GenVivo; Ipsen (I)
Stock and Other Ownership Interests - Eurocine Vaccines (I); Merck; Merck (I); Roche
Consulting or Advisory Role - Gerson Lehrman Group (I); MJH Life Sciences (I); Virothera (I)
Patents, Royalties, Other Intellectual Property - GenVivo, Inc. Patents Issued and Pending
Travel, Accommodations, Expenses - Adjuvance (I); GenVivo; Ipsen (I); Virothera (I)
 
Erin Miller
No Relationships to Disclose
 
Mallorie Jones
No Relationships to Disclose
 
Daniela Uribe
No Relationships to Disclose
 
E. Paul Wileyto
No Relationships to Disclose
 
Robert H. Vonderheide
Consulting or Advisory Role - BMS GmbH & Co. KG
Patents, Royalties, Other Intellectual Property - Inventor on a licensed patient regarding cancer vaccine antigens; Receives royalties from Children’s Hospital Boston for a licensed research-only monoclonal antibody
 
Carmen Guerra
Leadership - Freenome; GlaxoSmithKline; GRAIL; Guardant Health
Stock and Other Ownership Interests - BEAM Therapeutics; crispr therapeutics; Editas Medicine; Intellia Therapeutics
Consulting or Advisory Role - AstraZeneca (I)
Speakers' Bureau - Esperion Therapeutics (I); Janssen (I)
Research Funding - Genentech (Inst)
Travel, Accommodations, Expenses - Esperion Therapeutics (I)